Source:http://linkedlifedata.com/resource/pubmed/id/20874662
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2010-11-15
|
pubmed:abstractText |
Ischemia-modified albumin has been proposed as a useful rule-out marker for the diagnosis of acute coronary syndrome in the emergency department.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1366-5804
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
655-62
|
pubmed:meshHeading | |
pubmed:year |
2010
|
pubmed:articleTitle |
Current role of ischemia-modified albumin in routine clinical practice.
|
pubmed:affiliation |
Hospital Universitario de Canarias, Department of Cardiology, Tenerife, Spain. adrvdg@hotmail.com
|
pubmed:publicationType |
Journal Article,
Review
|